Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
3 results loaded, newest first. End of these results.
bioAffinity Technologies reported sales of its CyPath Lung test for lung cancer increased more than 100% through the third quarter of 2026 compared to 2025. The number of ordering physicians increased by 89% in Q3 2026 compared to Q3 2025.
bioAffinity Technologies announced that sales of its CyPath® Lung test for lung cancer increased more than 100% through the third quarter of 2026.
bioAffinity Technologies reported that sales for its CyPath Lung product more than doubled through Q3 2026 compared to the previous year.